Intelligence desk 12 languages Signal over noise

Bio Tech Radar

Strategic intelligence for senior leadership at a metabolomics and multiomics service provider, tracking competitive moves, regulatory shifts, and customer demand in US and European biotech markets.

Stay ahead of the competitive metabolomics landscape: track mergers, new platform launches (Bruker timsTOF, Sciex Triple Quad), and shifts in pharma/academic outsourcing trends.

About us

Why this desk matters

Curated relevance

Track competitor moves: monitor Metabolon’s HD4 platform updates, Quest’s test menu expansions, and Eurofins’ acquisition strategy with weekly curated briefings from 200+ industry sources.

Pattern-aware briefings

Regulatory radar: get early alerts on FDA CLIA/CAP policy changes, EMA IVDR implementation timelines, and NIH data-sharing mandates that affect your lab’s compliance and customer contracts.

Cross-language clarity

Customer intelligence: surface unmet needs in microbiome sequencing (16S vs shotgun metagenomics) and multiomics integration by analyzing publications, conference abstracts, and RFPs from big pharma and academic consortia.

Latest Spotlight

Open archive
Metabolite Glues as Purine Sensors and Chemotherapeutic Targets: Implications for Drug Discovery, MS-Based Screening, and Omics Landscape

2026-07-19 09:02 UTC

UC Berkeley 2026 study reveals purine nucleotides as endogenous molecular glues tethering PPAT to NUDT5, with conformational flexibility enabling rational thiopurine design. This discovery challenges conventional MS-based interaction screens, necessitates new bioinformatics tools for dynamic PPI modeling, and signals emerging licensing strategies and competitive positioning among omics service providers.

Want to run a Spotlight on a custom topic?

Run your own

Latest briefing

Open archive
Metaproteomics standardization advances; microbiome studies link dysbiosis to disease risk.

2026-07-21 - 2026-07-27 · 7 days

This week's research was dominated by community-driven efforts to standardize metaproteomics and microbiome studies, coupled with key findings linking microbiome dysbiosis to health outcomes. The Metaproteomics Initiative published a reporting checklist to improve reproducibility and FAIR compliance, alongside a review

  • Metaproteomics Initiative releases standardized reporting checklist, addressing reproducibility gaps in metaproteomics studies.
  • Community benchmarking of microprotein detection finds only 3.5% peptide replication across 12 studies; immunopeptidomics yields higher confidence than conventional proteomics.

Recent posts

View all